Effect of a Phone Reminder System on Patient-centered Tuberculosis Treatment Adherence Among Adults in Northwest Ethiopia: a Randomised Controlled Trial
Overview
Public Health
Affiliations
Objectives: This study aimed to evaluate the effect of the phone reminder system on patient-centred TB treatment adherence during continuation phase, where patients are responsible for taking medication at home.
Methods: We conducted a two-arm randomised controlled trial on adult patients with TB during the continuation phase. In the intervention arm, patients received routine care plus phone-based weekly pill refilling and daily medication reminders. In the control arm, participants received only routine care. A covariate adaptive randomisation technique was used to balance covariates during allocation. The primary outcome was adherence to patient-centred TB treatment, and secondary outcomes included provider-patient relationship and treatment outcomes. We applied per-protocol and intention-to-treat analysis techniques.
Results: We randomised 306 patients to intervention (n=152) and control (n=154) groups. Adherence to patient-centred TB treatment was 79% (110/139) in intervention and 66.4% (95/143) in control groups, with relative risk (RR) (95% lower CI) (RR=1.632 (1.162 to ∞); p=0.018, one tailed). Good provider-patient relationship was 73.3% (102/139) in intervention group and 52.4% (75/143) in control group, p=0.0001. TB treatment success was 89.5% (136/152) in intervention group and 85.1% (131/154) in control group, p=0.1238.
Conclusions: Mobile phone-based weekly refilling with daily medication reminder system improved adherence to patient-centred TB treatment and provider-patient relationship; however, there was no significant effect on treatment success.
Trial Registration Number: Pan African Clinical Trials Registry (PACTR201901552202539).
Chilala C, Foster N, Bahukudumbi S, Mohamed M, Zary M, Kafie C BMJ Glob Health. 2025; 10(2).
PMID: 39947715 PMC: 11831268. DOI: 10.1136/bmjgh-2024-016535.
Walle A, Hunde M, Demsash A BMJ Open. 2023; 13(12):e070813.
PMID: 38149411 PMC: 10711927. DOI: 10.1136/bmjopen-2022-070813.
Hassani S, Mohammadi Shahboulagi F, Foroughan M, Nadji S, Tabarsi P, Ghaedamini Harouni G Can J Infect Dis Med Microbiol. 2023; 2023:4056548.
PMID: 36937803 PMC: 10017217. DOI: 10.1155/2023/4056548.
Zhang M, Wang G, Najmi H, Yaqoob A, Li T, Xia Y Front Public Health. 2023; 11:1033532.
PMID: 36935730 PMC: 10014893. DOI: 10.3389/fpubh.2023.1033532.
Jerene D, Levy J, van Kalmthout K, van Rest J, McQuaid C, Quaife M BMJ Open. 2023; 13(3):e068685.
PMID: 36918242 PMC: 10016242. DOI: 10.1136/bmjopen-2022-068685.